SCHEMBL21274792

SCHEMBL21274792

CN(C)C(=O)c1ccc(Oc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.85
ALDH1A1 P00352 2/20 0.85
SMN1; SMN2 Q16637 2/20 0.85
PARP15 Q460N3 1/20 0.58
PARP10 Q53GL7 1/20 0.58
SRD5A2 P31213 4/20 0.56
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
RAB9A P51151 2/20 0.50
MAPT P10636 1/20 0.50
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
RXRG P48443 1/20 0.49
KMT2A Q03164 2/20 0.48
LPAR1 Q92633 3/20 0.48
LPAR5 Q9H1C0 3/20 0.48
CSNK2A1 P68400 1/20 0.47
MEN1 O00255 1/20 0.47
ATM Q13315 1/20 0.47
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11486845 0.89 SMN1; SMN2 (0.85) HPGDALDH1A1SMN1; SMN2PARP10SRD5A2
SCHEMBL458926 0.88 ALDH1A1 (0.61) HPGDALDH1A1SMN1; SMN2SRD5A2CA1
SCHEMBL5612757 0.85 HPGD (0.85) HPGDALDH1A1SMN1; SMN2PARP15PARP10
Ethane SCHEMBL11219716 0.83 PARP10 (0.72) HPGDALDH1A1SMN1; SMN2PARP15PARP10
SCHEMBL22281 0.83 PARP10 (0.78) HPGDALDH1A1PARP15PARP10SRD5A2
SCHEMBL5581520 0.83 PARP10 (0.78) HPGDALDH1A1PARP15PARP10SRD5A2
SCHEMBL766069 0.83 PARP10 (0.78) HPGDALDH1A1PARP15PARP10SRD5A2
Terephthalic Acid SCHEMBL9861713 0.83 PARP10 (0.78) HPGDALDH1A1PARP15PARP10SRD5A2
SCHEMBL5612755 0.83 HPGD (0.81) HPGDALDH1A1SMN1; SMN2PARP15PARP10
SCHEMBL5937241 0.82 CSNK2A1 (0.62) HPGDALDH1A1SMN1; SMN2MAPTRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868055-B Inhibitors of TRPC6 勃林格殷格翰国际有限公司 2024-03-08 CN disclosed
US-11370771-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-06-28 US disclosed
US-11370771-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-06-28 US disclosed
US-20210053935-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-02-25 US disclosed
US-20210053935-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-02-25 US disclosed
EP-3752503-A1 INHIBITORS OF TRPC6 Boehringer Ingelheim International GmbH (DE) 2020-12-23 EP disclosed
CN-111868055-A Inhibitors of TRPC6 勃林格殷格翰国际有限公司 2020-10-30 CN disclosed
WO-2019161010-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-22 WO disclosed
WO-2019161010-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053935-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC4 HPGD 3695/4885ALDH1A1 3340/4885SMN1; SMN2 3612/4885
US-11370771-B2 Inhibitors of TRPC6 TRPC6, TRPC1, TRPC4 HPGD 3695/4885ALDH1A1 3340/4885SMN1; SMN2 3612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.